annb0t
Top 20
Telix Pharmaceuticals Limited
MELBOURNE, Australia and INDIANAPOLIS, April 22, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today provides an update on its commercial and operational performance for the quarter ended 31 March 2025 (Q1 2025). All figures are in $US unless stated otherwise.
Strong Q1 2025 revenue growth
Q1 2025 unaudited revenue of approximately $186 million represents an increase of 62% over the prior year corresponding ...
>>> Read more: Telix Reports US$186M Q1 Revenue, Up 62% YOY
MELBOURNE, Australia and INDIANAPOLIS, April 22, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today provides an update on its commercial and operational performance for the quarter ended 31 March 2025 (Q1 2025). All figures are in $US unless stated otherwise.
Strong Q1 2025 revenue growth
Q1 2025 unaudited revenue of approximately $186 million represents an increase of 62% over the prior year corresponding ...
>>> Read more: Telix Reports US$186M Q1 Revenue, Up 62% YOY
